Related Experiment Videos
[Unsaturated fatty acids in diabetes mellitus]
Vutreshni Bolesti
|January 1, 1989
Summary
In diabetes mellitus type II, specific unsaturated fatty acids change in serum and high-density lipoproteins. These alterations may contribute to vascular complications, potentially normalizing with improved glucose control.
Area of Science:
- Biochemistry
- Metabolic Disorders
- Cardiovascular Health
Background:
- Diabetes mellitus type II is associated with altered lipid profiles.
- Vascular complications are a major concern in diabetes.
- Unsaturated fatty acids play a role in cardiovascular health.
Purpose of the Study:
- To investigate the levels of specific unsaturated fatty acids in serum and HDL of patients with type II diabetes.
- To compare these levels with healthy controls.
- To explore the relationship between fatty acid changes and diabetes compensation.
Main Methods:
- Analysis of serum and high-density lipoprotein (HDL) unsaturated fatty acids.
- Comparison between decompensated diabetes, compensated diabetes, and healthy controls.
- Quantification of linoleic, linolenic, eicosadienoic, eicosatrienoic, arachidonic, and eicosapentaenoic acids.
Main Results:
- Decompensated diabetes showed decreased linolenic, eicosadienoic, arachidonic, and eicosapentaenoic acids.
- Linoleic and eicosatrienoic acids increased in decompensated diabetes.
- Fatty acid levels tended toward normalization after carbohydrate metabolism compensation.
- Parallel changes in serum and HDL fatty acids suggest HDL reflects serum levels.
Conclusions:
- Unsaturated fatty acid profiles are altered in type II diabetes mellitus.
- These alterations may be linked to vascular lesions in diabetes.
- HDL fatty acid composition appears dependent on serum fatty acid levels.